We combine peer-reviewed scientific research with practical applications to develop evidence-based solutions for metabolic health. Our content and program protocols follow a structured review process:
An estimated 89.8 million Indian adults aged 20–79 lived with diabetes in 2024 — 1 in every 7 diabetes cases worldwide, projected to reach 156.7 million by 2050.
Nearly one in four Indian adults aged 15–49 is overweight or obese (BMI ≥ 25), up sharply from 2005 — measured across urban and rural India.
A nationwide study of nearly 9,000 Indian women aged 18–40 found 19.6% had PCOS by Rotterdam criteria, with obesity and dyslipidemia highly prevalent among them.
A meta-analysis of 50 Indian studies (23,581 adults) estimated fatty liver (NAFLD) in 38.6% of adults — rising to 52.8% in high-risk groups with obesity or diabetes.
An estimated 136 million Indians had prediabetes in 2021 (15.3% of adults) — the stage where insulin resistance has already taken hold, years before diabetes onset.
A meta-analysis of 111 Indian studies (133,926 adults) estimated metabolic syndrome in 30% of adults — 32% urban vs 22% rural, higher in women (35%) than men (26%).
A door-to-door survey of 4,767 North Indian adults found 4% met Rome III IBS criteria, while 17.3% reported abdominal pain, 11.6% constipation and 11.4% diarrhea.
About 1 in 6 people worldwide experience infertility — a disease of the reproductive system with major metabolic and hormonal drivers, including PCOS and thyroid disorders.
An eight-city study of 5,360 Indian adults found hypothyroidism in 10.95% — 15.86% of women vs 5.02% of men — with 3.47% previously undetected.
Our health content cites tier-1 authoritative sources. Key references include:
Clinical guidelines for diabetes management referenced in our type 2 diabetes content.
Primary source for diabetes, fatty liver, and metabolic condition information.
Evidence base for PCOS lifestyle and medical management recommendations.
Global framework for metabolic disease prevention and lifestyle interventions.
For questions about our methodology or to discuss research collaboration, contact support@morfresearch.com.